Brian Henry
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Parkinson's Disease Mechanisms and Treatments, Receptor Mechanisms and Signaling, Drug Solubulity and Delivery Systems
Most-Cited Works
- → Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?(2009)1,873 cited
- → Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease(1998)187 cited
- → Characterisation of human saliva as a platform for oral dissolution medium development(2015)169 cited
- → Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease(2002)162 cited
- → Effect of Repeatedl-DOPA, Bromocriptine, or Lisuride Administration on Preproenkephalin-A and Preproenkephalin-B mRNA Levels in the Striatum of the 6-Hydroxydopamine-Lesioned Rat(1999)157 cited
- → The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's disease(1999)134 cited
- → μ- and δ-Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease(2001)131 cited
- → Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan(2001)80 cited
- → Phencyclidine (PCP)-Induced Disruption in Cognitive Performance is Gender-Specific and Associated with a Reduction in Brain-Derived Neurotrophic Factor (BDNF) in Specific Regions of the Female Rat Brain(2010)65 cited
- → Potential of Opioid Antagonists in the Treatment of Levodopa-Induced Dyskinesias in Parkinson??s Disease(1996)64 cited